; and (v) not less than 3 representatives from professional medical societies. (2) Physician requirement Of the members appointed under paragraph (1), not less than one-half shall be physicians. (d) Term; vacancies (1) In general A member shall be appointed for a term of 3 years. (2) Vacancies A vacancy on the Coordinating Committee shall be filled in the same manner as the original appointment was made. (e) Reappointment The Secretary may reappoint a member of the Coordinating Committee to an unlimited number of terms. (f) Chair The Secretary shall appoint the chair of the Coordinating Committee. (g) Plan Not later than 1 year after the date of the enactment of this section, the Coordinating Committee shall develop and implement a plan (and update such plan every 3 years thereafter), in consultation with a broad range of scientists, patients, clinicians, and advocacy groups, on prostate cancer research programs and activities carried out by Federal agencies. Such plan shall include the following: (1) The identification of existing prostate cancer programs and activities of the— (A) the Department of Health and Human Services, including the National Institutes of Health; (B) the Department of Defense; and (C) the Department of Veterans Affairs. (2) An evaluation on research with respect to the underlying causes, prevalence, treatment, and mortality of prostate cancer, including any disparity among African-American and other high-risk men (defined as men who have a family history of prostate cancer, a genetic predisposition for prostate cancer, or developed cancer due to exposure to certain chemical and radiological agents). (3) With respect to prostate cancer— (A) an evaluation on the effectiveness of current screening and diagnostic techniques